MBP and myeloid sarcoma: Evidence also comes from a humanized mouse model: transgenic mice expressing the MS-associated DR2-molecule (DRA*0101/DRB1*1501), an MBP-specific TCR derived from MS patients and human CD4 develop disease with symptoms very similar to those in MS and more severe symptoms than mice lacking CD4 expression (83).